Retrospective Study
Copyright ©The Author(s) 2022.
World J Clin Cases. Oct 6, 2022; 10(28): 10042-10052
Published online Oct 6, 2022. doi: 10.12998/wjcc.v10.i28.10042
Table 4 Comparison of general data between the breast-conserving group and the modified radical treatment group
Group
Breast-conserving group
Modified radical cure group
t/χ2
P value
n6941
Age (yr)37.1 ± 7.139.2 ± 6.8-1.5230.131
BMI (kg/m2)23.9 ± 1.923.2 ± 1.71.9410.055
Affected side distribution, n (%)Left side34 (49.28)25 (60.98)1.4160.243
Right side35 (50.72)16 (39.02)
Lesion diameter (cm)2.18 ± 0.682.34 ± 0.70-1.180.24
Pathology typeInvasive ductal carcinoma43 (62.32)23 (56.1)2.1710.538
Ductal carcinoma in situ15 (21.74)7 (17.07)
Lobular carcinoma in situ6 (8.70)7 (17.07)
Other types5 (7.25)4 (9.76)